Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G de Groot

Showing results (181-190 of 275) with videos related to

Pageof 28
Sort By:
Neurology|August 26, 1998
Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosusR C Donders, L J Kappelle, R H Derksen, et al.
Thrombosis Research|October 8, 2014
Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assayR Loeffen, R van Oerle, P G de Groot, et al.
Journal of Thrombosis and Haemostasis : JTH|May 2, 2007
Platelets express three different splice variants of ApoER2 that are all involved in signalingM T T Pennings, R H W M Derksen, R T Urbanus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interactionY P Wu, T Vink, M Schiphorst, et al.
Thrombosis and Haemostasis|July 1, 1995
Platelet adhesion to collagenJ J Sixma, G H van Zanten, E U Saelman, et al.
Journal of Vascular Research|March 1, 1996
Thrombogenicity of the human arterial wall after interventional thermal injuryM J Post, A N de Graaf-Bos, H G van Zanten, et al.
British Journal of Haematology|June 19, 2001
Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfacesM J Simmelink, D A Horbach, R H Derksen, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control studyT C Van Holten, M Roest, J Riphagen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1996
Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factorY P Wu, H H van Breugel, H Lankhof, et al.
The Journal of Cardiovascular Surgery|June 5, 2004
In vivo transluminal microvascular endothelial cell seeding on balloon injured rabbit arteriesC H Arts, P G De Groot, N Attevelt, et al.
Pageof 28

Showing results (181-190 of 275) with videos related to

Sort By:
Pageof 28
Neurology|August 26, 1998
Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosusR C Donders, L J Kappelle, R H Derksen, et al.
Thrombosis Research|October 8, 2014
Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assayR Loeffen, R van Oerle, P G de Groot, et al.
Journal of Thrombosis and Haemostasis : JTH|May 2, 2007
Platelets express three different splice variants of ApoER2 that are all involved in signalingM T T Pennings, R H W M Derksen, R T Urbanus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interactionY P Wu, T Vink, M Schiphorst, et al.
Thrombosis and Haemostasis|July 1, 1995
Platelet adhesion to collagenJ J Sixma, G H van Zanten, E U Saelman, et al.
Journal of Vascular Research|March 1, 1996
Thrombogenicity of the human arterial wall after interventional thermal injuryM J Post, A N de Graaf-Bos, H G van Zanten, et al.
British Journal of Haematology|June 19, 2001
Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfacesM J Simmelink, D A Horbach, R H Derksen, et al.
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control studyT C Van Holten, M Roest, J Riphagen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1996
Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factorY P Wu, H H van Breugel, H Lankhof, et al.
The Journal of Cardiovascular Surgery|June 5, 2004
In vivo transluminal microvascular endothelial cell seeding on balloon injured rabbit arteriesC H Arts, P G De Groot, N Attevelt, et al.
Pageof 28